Podcasts about Leukemia

In this moving episode of Supply Chain Now, host Scott Luton sits down with Kristi Porter, Adrian Purtill, and Enrique Alvarez of Vector Global Logistics to explore a powerful story of purpose and community. Adrian shares a deeply personal initiative in honor of his late ex-wife, Kathy Purtill, who bravely battled leukemia. To carry her legacy forward, their son Kieran is climbing Mount Kilimanjaro to raise funds for the Leukemia & Lymphoma Society.This conversation goes beyond logistics, shining a light on the value of giving forward, building community, and leading with purpose. The Vector Global Logistics team reflects on how purpose-driven action can change lives—both in the global supply chain and beyond.Learn how you can support Kieran's mission, and be inspired to embrace the power of relationships, resilience, and purpose.Additional Links & Resources:Kathy Purtill's fundraising page for The Leukemia and Lymphoma Society: https://diy.lls.org/fundraiser/6467059Connect with Enrique: https://www.linkedin.com/in/enrique-alvarez-64332a2/Connect with Kristi: https://www.linkedin.com/in/kporter9876/Connect with Adrian: https://www.linkedin.com/in/adrian-purtill-947a2b5/Learn more about Vector Global Logistics: https://vectorgl.com/Learn more about Logistics with Purpose: https://logisticswithpurpose.co/Learn more about Supply Chain Now: https://supplychainnow.comWatch and listen to more Supply Chain Now episodes here: https://supplychainnow.com/program/supply-chain-nowSubscribe to Supply Chain Now on your favorite platform: https://supplychainnow.com/joinWork with us! Download Supply Chain Now's NEW Media Kit: https://bit.ly/3XH6OVkWEBINAR- Mastering Data in the AI Explosion Age - Managing the Fuel That Powers Innovation: https://bit.ly/4ogPN1kWEBINAR- Real stories: Fast-tracking value, a pioneering digital transformation with impactful results.: https://bit.ly/4mgp1EWWEBINAR: Real Shipping Stories. Real Money Saved.: https://bit.ly/45PegUmWEBINAR: From Compliance to Impact and Competitive Advantage: How to Decarbonize Your Supply Chain: https://bit.ly/47uXKKoThis episode is hosted by Scott Luton and produced by Trisha Cordes, Joshua Miranda, and Amanda Luton. For additional information, please visit our dedicated show page at: https://supplychainnow.com/honoring-legacy-moving-climbing-mountains-1473

Dr Azra Raza is a Professor of Medicine, Clinical Director of the Evans Foundation MDS Center, and Executive Director of The First Cell Coalition for Cancer Survivors at Columbia University in New York. She is the best-selling author of "The First Cell: And the human costs of pursuing cancer to the last". She started her research in Myelodysplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010. Before moving to New York, Dr Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer-reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, the British Journal of Hematology, Leukemia, and Leukemia Research. Dr Raza serves on numerous national and international panels as a reviewer, consultant, and advisor and is the recipient of a number of awards.TIMESTAMPS:(0:00) - Introduction (0:50) - The First Cell: and the human costs of pursuing cancer to the last(4:10) - Defining Cancer(7:50) - A Cancer Paradigm Shift: Finding the First Cell(11:16) - "The Cure for Cancer"(19:05) - Azra's Journey, Development & Reception(24:40) - Hope, Honesty & Harm in a Clinical Setting(33:00) - Current Medical Politics vs Revolutionary Detections/Treatments(39:00) - Increasing Lifespan & Healthspan(43:01) - "Michael Levin Should Win The Nobel Prize!"(51:00) - A Good Life & a Good Death(56:00) - How Words distort our relationship with Disease(1:00:00) - How Disease & Death Shape Our Lives(1:05:40) - The First Cell Book(1:09:15) - A Better Healthcare System(1:12:27) - Conclusion EPISODE LINKS:- Azra's Website: https://azraraza.com- Azra's Books: https://azraraza.com/books- Azra's X: https://x.com/AzraRazaMD- Azra's YouTube: http://www.youtube.com/@AzraRazaMDCONNECT:- Website: https://tevinnaidu.com - Podcast: https://creators.spotify.com/pod/show/mindbodysolution- YouTube: https://youtube.com/mindbodysolution- Twitter: https://twitter.com/drtevinnaidu- Facebook: https://facebook.com/drtevinnaidu - Instagram: https://instagram.com/drtevinnaidu- LinkedIn: https://linkedin.com/in/drtevinnaidu=============================Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

In this week's episode we'll learn about how by combining PET response with circulating tumor DNA, or  ctDNA, in newly treated patients with follicular lymphoma, investigators identify those patients likely to progress within 24 months of initial treatment, also known as POD24. After that: Immune hotspots in aplastic anemia. These newly identified hotspots potentially represent sites in the bone marrow where the active immune response takes place, driving the destruction of hematopoietic stem and progenitor cells. Finally, allogeneic transplantation for Hodgkin lymphoma in the checkpoint inhibitor era. In a large, retrospective study, patients with prior checkpoint inhibitor exposure had remarkable outcomes, particularly when post-transplant cyclophosphamide was used.Featured Articles: Combined PET and ctDNA response as predictors of POD24 for follicular lymphoma after first-line induction treatmentImaging Mass Cytometry Reveals the Order of Events in the Pathogenesis of Immune-Mediated Aplastic AnemiaOutcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis

In this week's episode, we'll learn more about how exogenous CD19 stimulation affects CAR T-cell persistence in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy; new algorithms that incorporate sequential rapid immune-assays, intended to improve diagnosis of heparin-induced thrombocytopenia, and resource-adaptive survival prediction models to help guide management of patients with chronic myelomonocytic leukemia.Featured Articles:Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALLSequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopeniaBLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemia

Dan Shaughnessy has watched The Jimmy Fund evolve throughout his time in Boston sports media. He also is confident that the Red Sox are a playoff team this season.

In this episode, Associate Blood editor Dr. Selina Luger leads a discussion with Drs. Courtney DiNardo, Eunice Wang, Andrew Wei and Gail Roboz about the advances in treatment options for Acute Myeloid Leukemia (AML). See the full How I Treat series on Acute Myeloid Leukemia in volume 145 issue 12 of Blood journal.

This week we explore the Pharaoh's tomb with Rachel and possibly discover the cause of the Curse of the Pharaoh. What's more, can it cure cancer? Rachel takes a look at Aspergillus fungus, how it causes disease but also has been used in experiments to cure Leukemia. Victoria is up next with a fascinating look at how spiders might be manipulating the flashing of fireflies in order to attract more prey. It's brand new research and wild. Kirk rounds out the show this week with a look at Mt Erebus in Antarctica. Not only is the most active volcano in the southern hemisphere, it has a permanent lava pool surrounded by snow and rains gold on Antarctica. This is a bizarre volcano. Join us weekly for more strange nature. Our supporters on Patreon get every episode ad-free!  Support us: patreon.com/strangebynature Email us: contact@strangebynaturepodcast.com Visit us at: strangebynaturepodcast.com  where you can sign up for our episode emails.

In this episode, we sit down with Abby Singh, a melanoma survivor diagnosed as an Adolescent and Young Adult (AYA). Abby is now the Director of Patient Content and Nutrition Education Services at The Leukemia & Lymphoma Society (LLS), where she creates critical resources for patients and caregivers, including the Survivorship Workbooks.She shares her journey through diagnosis, treatment, and survivorship, and how her experience drives her work supporting nutrition programs for all cancer types. Abby also opens up about life beyond cancer—from her Tennessee roots in Sevierville (Dolly Parton's hometown) to her passions for fiction writing, bar trivia, and family life.Join us for an honest, inspiring conversation about resilience, healing, and the importance of community in the AYA cancer experience.ABOUT OUR GUEST: Abby Singh, a melanoma survivor and passionate advocate for cancer patients, serves as the Director of Patient Content at the Nutrition Education Services Center and The Leukemia & Lymphoma Society (LLS). In this role, she has dedicated over a decade to creating impactful resources like the Survivorship Workbooks and supporting LLS's comprehensive nutrition program, which benefits individuals with all types of cancer.A proud graduate of Belmont University in Nashville, TN, Abby holds a bachelor's degree in English and history. She is also a member of the Alpha Gamma Delta sorority. Outside of her professional work, Abby enjoys reading, writing fiction, and testing her knowledge at bar trivia. She lives in Sevierville, TN—Dolly Parton's hometown—with her husband, young son, and two beloved cats.

Welcome back to part three of our hematology series here at Every Day Oral Surgery! Today, Drs. Andrew Jenzer and Maxwell Lloyd join Dr. Stucki to discuss all things leukemia. Tuning in, you'll hear all about the different kinds of leukemia, how we differentiate between them, symptoms of leukemia, and so much more! We delve into specific characteristics of acute myelogenous leukemia and how to avoid leukocytosis before discussing the role chemotherapy plays in treating different types of leukemia and the two different kinds of transplants these patients can have. We go on to discuss chronic myelogenous leukemia, the different phases associated with it, how chemotherapeutic medications may affect oral surgery procedures, how acute lymphocytic leukemia differs from other forms of leukemia, and how it's treated. Lastly, we dive into the most common kind of leukemia, chronic lymphocytic leukemia, the staging and prognosis of it, and so much more. This episode is jam-packed with important information that you don't want to miss out on, so be sure to press play now and tune in for the next episode!Key Points From This Episode:Welcoming today's guest, Dr. Maxwell Lloyd. A breakdown of some of the vocabulary doctors use in hematological care. What leukemia is and how we classify what kind of leukemia a patient has. Some general characteristics of all kinds of leukemia. Dr. Jenzer breaks down the characteristics of myeloid leukemia.What leukocytosis is, why it's so dangerous, and how we prevent it. How doctors treat AML (acute myelogenous leukemia). Using chemotherapy to treat leukemia and why it isn't enough on its own. The differences between autologous and allogeneic transplants. Breaking down CML (chronic myelogenous leukemia) and its phases.What ALL (acute lymphocytic leukemia) is and treatment options for it. We dive into the most common form of leukemia, CLL (chronic lymphocytic leukemia). Some important things to know about BTK inhibitors. Links Mentioned in Today's Episode:Dr. Andrew Jenzer — https://www.quintessence-publishing.com/usa/en/author/3920767/jenzer-andrew-clark Dr. Maxwell Lloyd Google Scholar — https://scholar.google.com/citations?user=D0agka0AAAAJ&hlSr. Louis OMFS Review — https://stlomfsreview.com/ Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

In this week's episode, we'll learn more about the effects of daratumumab maintenance on minimal residual disease in patients with newly diagnosed, transplant-eligible multiple myeloma; the role of neutrophils in the pathophysiology of myeloproliferative neoplasms; and a genome-wide association study that identified novel genetic loci associated with the risk of heavy menstrual bleeding.Featured ArticlesDaratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease resultsDefective neutrophil clearance in JAK2^V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24Genome-wide meta-analysis of heavy menstrual bleeding reveals 36 risk loci

Shortly after Jonathan Pacheco was married, he unexpectedly found himself in the middle of the biggest trial of his life: leukemia. Given only months to live, he discovered rest and peace in the Lord and surrendered himself to God's will... when God worked yet another miracle. ++++++++++++ Compelled is a seasonal podcast using gripping, immersive storytelling to celebrate the powerful ways God is transforming Christians around the world. These Christian testimonies are raw, true, and powerful. Be encouraged and let your faith be strengthened! Want to help make new episodes? Either make a one-time gift, or become a Monthly Partner at: https://compelledpodcast.com/donate Perks of being a Monthly Partner include: EARLY ACCESS to each new Compelled episode 1 week early! FULL LIBRARY of our unedited, behind-the-scenes interviews with each guest... over 100+ hours of additional stories and takeaways! Become a Monthly Partner by selecting the "Monthly" option during check-out.  Show notes, emails, and more at: https://compelledpodcast.com Buy the Compelled book of testimonies, endorsed by Lee Strobel, Marvin Olasky, and more: https://compelledpodcast.com/book Compelled is a member of the Proclaim Podcast Network: https://proclaim.fm Learn more about your ad choices. Visit megaphone.fm/adchoices

Good Morning and E News: Hulk Hogan had leukemia, Taylor Swift in Happy Gilmore 2, Adam Sandler, Movies out this week, and Carrie Underwood.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this week's episode we'll learn more about enhanced transplant characteristics; targeting the JAK-STAT pathway with ruxolitinib in patients with adult-onset Still's disease and macrophage activation syndrome; and a pair of trials demonstrating lack of benefit for the anti-CD47 monoclonal antibody magrolimab in newly diagnosed acute myeloid leukemia.Featured ArticlesHeterogeneity of high-potency multilineage hematopoietic stem cells and identification of “Super” transplantabilityRuxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndromeMagrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 studyThe ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy

Interview with Melanie Comito, MD

In this podcast, Max S. Topp, MD, and Pier Luigi Zinzani, MD, PhD, explore the current and future implications of some of their top choices of studies in lymphomas and ALL presented at the EHA and ICML 2025 meetings.Program Abstracts: POLARGO: Rituximab, Gemcitabine and Oxaliplatin ± Polatuzumab Vedotin for R/R DLBCLECHO: Rituximab-Bendamustine ± Acalabrutinib in Untreated High-Risk MCLCADANCE-101: BGB-16673 BTK Degrader in R/R CLL/SLLInMIND: Tafasitamab, Lenalidomide, Rituximab in R/R FLSHR2554: Oral EZH2 Inhibitor in R/R PTCLSYRUS: AZD0486 Bispecific Antibody for R/R B-ALLPresenters:Max S. Topp, MDHead of Hematology and Clinical CAR-T Program LeadAssociated ProfessorMedinische Klinik und Poliklinkik IIUniversity of WurzburgWurzburg, GermanyPier Luigi Zinzani, MD, PhDProfessor of HematologyAlma Mater Studiorum- University of BolognaHead, “Seràgnoli” Institute of HematologyIRCCS Azienda Ospedaliero-Universitaria di BolognaDepartment of Medical and Surgical SciencesBologna University School of MedicineBologna, ItalyLink to full program:https://bit.ly/4obcJPI

Gedit, Gedit Friday! What would you do if you were a billionaire?... Flash house?, Help the issues of the world?, Retire your family?... Well the boys know what they'd do... Matua Marc came to the show a little while ago with his segment "Shell We" a chance for Shifters to share something they were proud about, their story, their rise through trials and tribulations, a safe place... Well a Shifter who wrote in back then, now has an update for us all... One that made the boys reflect... Deano Collins is not only a friend of the show but come the 5th of September, he is doing some unbelievable mahi... He is spending 24hrs going up against a boxing bag to raise funds and awareness for the Child Cancer Foundation as his Son Houston was diagnosed with Leukemia in 2023... Hit that link below to stay caught up with anything and everything TMS. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.facebook.com/groups/3394787437503676/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We dropped some merch! Use TMS for 10% off. Here is the link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youknowclothing.com/search?options%5Bprefix%5D=last&q=tms⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Thank you to the team at Chemist Warehouse for helping us keep the lights on, here at The Morning Shift... ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.chemistwarehouse.co.nz⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's episode, we'll learn about a JAK inhibitor to prevent complications of CD19-directed CAR T-cell therapy. In a phase 2 study, itacitinib was well tolerated and demonstrated promising reductions in the incidence of cytokine release syndrome and neurotoxicity. After that: investigators report direct interactions between ChAdOx1 and platelets under arterial shear conditions. Investigators say it's a novel biophysical mechanism that potentially contributes to post-vaccination arterial thrombosis. Finally, we explore lineage switch, an emerging form of acute leukemia relapse with dismal outcomes. It arises rapidly following antigen-targeted immunotherapy, highlighting the importance of advanced methods for detection and treatment.Featured Articles: Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 studyShear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosisProject EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Welcome to episode 201 of Sports Management Podcast. Today's guest is Geoff Thomas MBE – A former professional footballer, cancer survivor and a Patron of charity for Cure Leukaemia. When this episode is live, he just completed all the 21 stages of the Tour the France, raising vital funds for Cure Leukaemia, a cause close to his heart having overcome chronic myeloid leukaemia himself. We spoke about: His background as a professional footballer 9 caps with England without losing Being diagnosed with leukaemia and getting 3 months to live Giving back through charities How Arthrosamid® helped with his knee pain And much more! Time stamps:  00:03 Guest Background & Football Career   03:09 Cancer Diagnosis & Treatment Journey   09:51 Sports Mindset Application to Cancer Treatment   11:54 Tour de France Charity Challenge   15:00 Cure Leukaemia Charity Evolution   19:46 Physical Challenges & Recovery Strategy   21:22 Arthrosamid Knee Treatment   27:09 Mental Health & Support Advice   31:58 Future Goals & Network    Follow Sports Management Podcast on social media Instagram Twitter LinkedIn YouTube www.sportsmanagementpodcast.com

In this week's episode we'll learn more about the use of ruxolitinib plus dexamethasone to treat newly diagnosed patients with adult hemophagocytic lymphohistiocytosis; lysine-specific demethylase-1 inhibitors as a potential new class of therapies for sickle cell disease and other beta-globinopathies; and insights into clinical characteristics of patients with von Willebrand factor levels that are lower than normal but higher than those typically used to diagnose von Willebrand disease.Featured Articles:Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in ChinaNovel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse modelClinical phenotype and pathophysiological mechanisms underlying qualitative low VWF

On this Make A Difference Minute, teenager Lincoln Kallas of Hartselle, Alabama, shares a powerful glimpse into his journey battling leukemia and how the care he received at St. Jude Children's Research Hospital—and the support from his community—helped him through. From hospital stays to a surprise message from a Tennessee Vols player, Lincoln's story reminds us that even in the darkest moments, hope and encouragement can make all the difference. Sponsor: Premier Structures PremierStructures.com

In this episode, Associate Editor Dr. Philippe Armand discusses the Review Series on mantle cell lymphoma with author Dr. Christine Ryan. Both were authors of "Frontline management of mantle cell lymphoma", and discuss shifts in treatments and new research.Find the full review series in Volume 145 Issue 7 of Blood: "Review series on mantle cell lymphoma: sands shifting in the darkness"

In this episode of F-Stop Collaborate and Listen, host Matt Payne chats with photographer Geoffrey Giebelhaus about the Fediverse—a decentralized network of social media platforms like Mastodon and PixelFed that offer an alternative to the algorithm-driven, ad-heavy giants like Instagram and Facebook. Geoffrey breaks down what the Fediverse is, how it works, and why it's a great fit for photographers seeking a more ethical, community-focused space to share their work. The conversation covers the learning curve of moving to decentralized platforms, the importance of hashtags and alt text, tips for getting started, and how the Fediverse empowers users to keep their followers and content, no matter where they go. They also touch on the deeper creativity and connections fostered by this new social media landscape, and close with Geoffrey's advocacy for the Leukemia and Lymphoma Society of Canada. If you're fed up with mainstream social media and want to learn about a more authentic and user-driven alternative, this episode is for you. Links: Geoff's awesome blog about the Fediverse Support the podcast on Patreon Join my newsletter The Leukemia & Lymphoma Society  

Send us a textJonathan Daige is an Army veteran with two deployments to Iraq. A retired Worcester Police officer of 18 years and served 8 years on the SWAT Team as a sniper. Within that time he has battled testicular cancer that spread all over his body from his chest to his brain multiple times. After cycling to heal he began a nonprofit Thin Blue Ride that helps military veterans, first responders and their families when battling cancer. Since 2017 Thin Blue Ride has raised over $800,000 for families across the country. JD now medically retired has been battling Leukemia for several years and is continuing to help cancer warriors whenever he can. Find Jonathan DaigeWebsiteFind The Suffering PodcastThe Suffering Podcast InstagramKevin Donaldson InstagramTom Flynn InstagramApple PodcastSpotifyYouTubeThe Suffering Podcast FamilySherri AllsupSupport the showThe Suffering Podcast Instagram Kevin Donaldson Instagram TikTok YouTube

In this week's episode, we'll learn about rapid, high-sensitivity diagnostic assays for TTP, or thrombotic thrombocytopenic purpura, that can reduce unnecessary treatments. After that: enhancing PD-1 blockade in relapsed/refractory extranodal NK/T-cell lymphoma. In a single-arm, phase 2 study, combined CD38 and PD-1 inhibition demonstrated durable responses and manageable safety. Finally, a lymphoma horror story with a happy ending. CREBBP mutations create a zombie enzyme that competes with its wild-type counterparts. By enforcing CD40 signaling, a bispecific antibody overcomes this effect and induces lymphoma cell death.Featured Articles:Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysisEfficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphomaBlunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement

ICYMI, this hot take episode originally aired in April of this year. One of America's most notorious TV moms sat down with me and gave me a great interview. Barbara Bregoli, the mother of Danielle Bregoli, famously known as Bhad Bhabie or the "Cash Me Outside" girl. Barbara shared her life story, from her Brooklyn upbringing and career in finance to the challenges of being a single mother. She opened up about the infamous Dr. Phil appearance, clarifying misconceptions and discussing Bhad Bhabie's evolution into a rapper. Barbara also revealed her personal battles with breast cancer and the impact on her family, as well as the recent news of Dani's leukemia diagnosis. Through it all, Barbara's resilience and unwavering support for her daughter shone brightly, offering a deeply personal and inspiring narrativeTimestamps:00:00:00 - Introduction and Guest Welcome00:00:20 - Barbara Bregoli's Background and Dr. Phil Appearance00:00:50 - The Origin of "Catch Me Outside" Phrase00:28:03 - Bhad Bhabie's Leukemia Diagnosis00:30:36 - Alabama Barker Feud, Bhad Bhabie's OF earnings and more00:35:17 - The Kardashian's, Bhad Bhabie's future goals and moreMY Go Big Podcasting Courses Are Here! Purchase Go Big Podcasting and learn to start, monetize, and grow your own podcast. Use code DAD15 for 15% OFF until 6/30/2025**SHOP my Amazon Marketplace - especially if you're looking to get geared-up to start your own Podcast!!!**https://www.amazon.com/shop/thesarahfrasershowShow is sponsored by:ASPCA Pet Insurance to explore coverage, visit A-S-P-C-A pet insurance dot com slash TSFS.Horizonfibroids.com get rid of those nasty fibroidsNutrafol.com use code TSFS for FREE shipping and $10 off your subscriptionQuince.com/tsfs for FREE shipping on your order and 365 day returnsRula.com/tsfs to get started today. That's R-U-L-A dot com slash tsfs for convenient therapy that's covered by insurance.Thrivecosmetics.com/tsfs Brighten a mom's day—especially if you're that mom. Go to thrivecausemetics.com/TSFS for 20% OFF your orderFollow me on Instagram/Tiktok: @thesarahfrasershow ***Visit our Sub-Reddit: reddit.com/r/thesarahfrasershow for ALL things The Sarah Fraser Show!!!***Advertise on The Sarah Fraser Show: thesarahfrasershow@gmail.comGot a juicy gossip TIP from your favorite TLC or Bravo show? Email: thesarahfrasershow@gmail.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Do we have another comet visiting from outside the solar system? What is Oumuamua? Is the Ring of Fire amping up in activity? Is leukaemia genetic? Does exposure to certain chemicals increase your risk of cancer? Why are early health screenings so important? How do you measure the risk of certain health treatments? Dr Chris Smith and Clarence Ford have all the answers... Like this podcast? Please help us by supporting the Naked Scientists

Do we have another comet visiting from outside the solar system? What is Oumuamua? Is the Ring of Fire amping up in activity? Is leukaemia genetic? Does exposure to certain chemicals increase your risk of cancer? Why are early health screenings so important? How do you measure the risk of certain health treatments? Dr Chris Smith and Clarence Ford have all the answers... Like this podcast? Please help us by supporting the Naked Scientists

Patty Furco's then 4 year old daughter Abby was diagnosed with Pre B Cell Acute Lymphoblastic Leukemia in 2011, a diagnosis which was changed 2 weeks later to Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia. This diagnosis reduced Abby's chances of survival to 20 percent. Patty will talk about the 10 years that Abby was able to somehow survive this very difficult form of Leukemia, which included her doctors saying that she had 48 hours to live in May of 2016. Patty and her husband very sadly began to make funeral arrangements and as Abby's time was supposedly nearing its end, somehow she recovered and was able to live another 5 years until her passing in October of 2021. 

In this week's episode we'll learn more about a novel mouse model that recapitulates many of the properties of human sickle cell SC disease; results from the induction phase of the risk-adapted MIDAS trial of isatuximab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed, transplant-eligible multiple myeloma; and a link between splicing factor mutations and competitive fitness in myelodysplastic syndrome stem cells.Featured articles:A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyureaIsatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trialCell-autonomous dysregulation of interferon signaling drives clonal expansion of SRSF2-mutant MDS stem/progenitor cells

Elaine Cooney joined PJ to talk about her cousin Aisling — a devoted young Mam who's now fighting leukemia with everything she has. Support Aisling here Fundraiser by Deborah Elaine : Help Aisling Thornhill on her journey with Leukemia Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Braun Performance & Rehab Podcast, Dan is joined by Alexa Degan to discuss her recovery from 2 ACL injuries. Alexa Degan is a resilient and driven ice hockey player currently competing at the collegiate level for Long Island University. A 2023 graduate of Morristown-Beard School, Alexa played four standout seasons of varsity hockey, helping her team secure three state championships and one co-championship. Over her freshman and sophomore seasons, she tallied seven goals and 25 assists, earning first-team all-state honors before overcoming the challenge of two ACL injuries that sidelined her.In addition to hockey, Alexa competed in two varsity lacrosse seasons and demonstrated strong leadership off the field as well. She co-captained a fundraising campaign that raised an impressive $122,000 for the Leukemia & Lymphoma Society, showcasing her commitment to making a broader impact.Alexa is the daughter of Christa and Sean Degan and has two brothers, Justin and Ayden. Her story is one of perseverance, leadership, and dedication—both on and off the ice.For more on Alexa, be sure to follow @torn2triumphant*SEASON 6 of the Braun Performance & Rehab Podcast is brought to you by Isophit. For more on Isophit, please check out isophit.com and @isophit -BE SURE to use coupon code BraunPR25% to save 25% on your Isophit order!**Season 6 of the Braun Performance & Rehab Podcast is also brought to you by Firefly Recovery, the official recovery provider for Braun Performance & Rehab. For more on Firefly, please check out https://www.recoveryfirefly.com/ or email jake@recoveryfirefly.com***This episode is also powered by Dr. Ray Gorman, founder of Engage Movement. Learn how to boost your income without relying on sessions. Get a free training on the blended practice model by following @raygormandpt on Instagram. DM my name “Dan” to @raygormandpt on Instagram and receive your free breakdown on the model.Episode Affiliates:MoboBoard: BRAWNBODY10 saves 10% at checkout!AliRx: DBraunRx = 20% off at checkout! https://alirx.health/MedBridge: https://www.medbridgeeducation.com/brawn-body-training or Coupon Code "BRAWN" for 40% off your annual subscription!CTM Band: https://ctm.band/collections/ctm-band coupon code "BRAWN10" = 10% off!Ice shaker affiliate link: https://www.iceshaker.com?sca_ref=1520881.zOJLysQzKeMake sure you SHARE this episode with a friend who could benefit from the information we shared!Check out everything Dan is up to by clicking here: https://linktr.ee/braun_prLiked this episode? Leave a 5-star review on your favorite podcast platform

In this powerful episode of the Medical Sales U Podcast, I sit down with Nick Rich—cancer survivor, AYA advocate, and now a Senior Oncology Account Specialist at Pfizer. Nick opens up about his deeply personal journey from battling cancer to building a career in oncology sales, where he now helps bring life-saving treatments to patients fighting the very diseases he once faced.We discuss how his diagnosis shaped his purpose, the pivotal moments that led him into medical sales, and how his fundraising team helped raise over $50,000 for the Leukemia and Lymphoma Society. You'll hear the grit behind his transition from patient to professional, and how he channels his pain into purpose every day on the job.Whether you're in sales, healthcare, or simply looking for inspiration, this conversation will move you. Nick's story is a testament to resilience, faith, and the impact of using your story to serve others.

Will Yank is a 2020 graduate from Wabash College who is also a member of Phi Gamma Delta Fraternity. At 21 years old, he was diagnosed with leukemia and septic shock, and now he speaks on reclaiming hope, something that is a very important lesson for us all to consider when life throws us a curveball and we start to feel pain, failure, or regret. Today we're going to hope for something. In episode 581 of the Fraternity Foodie Podcast, we find out why Will decided on Wabash College, what made him want to join Phi Gamma Delta Fraternity, what it was like to be diagnosed with leukemia and septic shock at 21 years old, why hope is more than just a “feel-good” emotion, why having a future vision so important for college students today, what we can do for students who feel like they have no one to lean on, how students can turn past pain, failure, or regret into a teacher instead of a burden, how to support members going through difficult mental health or life challenges, what is one action students can take right now to reclaim a sense of hope, and what his legacy will be for this generation of college students. Enjoy!

In this week's episode, we'll learn about using AI to assess transplant risk in myelofibrosis. In a step toward personalized medicine, researchers report on a machine learning model that identifies 25% of patients with poor outcomes. After that: preventing priapism in men with sickle cell anemia. A recent phase 2 feasibility study shows high rates of recruitment, retention, and adherence to oral therapies, coupled with a significant reduction in the risk of this difficult complication. Finally, new research indicates that hallmarks of terminal T-cell exhaustion are absent in multiple myeloma, from diagnosis through maintenance therapy. We explore these provocative and counterintuitive findings arising from profiling of blood and marrow samples.Featured Articles:Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosisA controlled trial for preventing priapism in sickle cell anemia: hydroxyurea plus placebo vs hydroxyurea plus tadalafilHallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy

When Laura's daughter was diagnosed with leukemia, her world stopped. What followed was a powerful journey through fear, resilience, and fierce advocacy. In this episode, Laura DeKraker Lang-Ree—a lifelong educator and now author of The Cancer Parent's Handbook—opens up about the most terrifying day of her life, how she transformed pain into purpose, and why parent-to-parent support is critical in the childhood cancer community. Her reflections are raw, heartfelt, and offer wisdom for every parent facing a medical diagnosis with their child. 

Cedar Connell was 15 years old when he found himself on his way to Lurie Children's Hospital in Chicago to begin his treatment for B Cell Acute Lymphoblastic Leukemia in 2022. Cedar and his mom Kiki will talk about the difficult treatment that he went through, including his move from Chicago to the Dana Farber Cancer Institute in Boston in 2023. Cedar is now getting ready to do his part for the Leukemia and Lymphoma Society as TEAM CONNELLSLLS will be getting ready for a 31 day challenge beginning on July 1st and ending on August 1st to exercise 3 miles each day for that time period, in the hope that they raise 35,000.

Omg Bravo Bosses! I interviewed Jared Lipscomb from The Valley and so we are skipping our typical reality roundup up today in favor of this interview which was chock FULL OF TEA! You can watch this episode on YouTube! If you don't know Jared, you're about to. Jared started off as the makeup artist for the Vandercrew and became a stable fixture in the lives of the cast members as they progressed to The Valley. Since Jared has been around for many years, he knows the truth about our favorite Bravo stars that we love to hate and he's ready to TELL ALL! We talked about Zach's demonic words that couldn't be said on tv, why he is furious at some cast members for being in the comments, what Dark Side Danny REALLY looks like as well as where the fans have it wrong about Janet. We also get into Jared's fascinating backstory in drag and in makeup, we talk about his cancer journey and lastly, Jared tells the story of how he was integrally involved in Britney Spears' conservatorship battle! Follow Jared on IG @jaredlips and Listen to This Side of the Hill wherever you get your podcasts! For more information on participation in and donations for Leukemia and Lymphoma follow: @llsusa and @nmdp_org Thank you to our SPONSORS! ⁠⁠⁠Petscosset ⁠⁠⁠- Use code: GS15 for 15% off any product! Doodle - Doodle is a user-friendly scheduling platform that helps individuals and teams easily find meeting times, book appointments, and organize events. For a limited time, get 20% off here with CODE: AFFILIATE-20. Rubbish Home - Rubbish makes garbage bags that make trash less day less painful and more enjoyable.We've made your garbage bag dreams come true with our 13-gallon trash bags. Each box includes a fun saying and a reminder when you're low on garbage bags. Our compostable, non-toxic, and PFAS-free trash bags break down quickly and 10% of our garbage bags go to charity. Rubbish does everything your current garbage bags don't! You can purchase my new RE-BRANDED The Bravo Investigator Merch ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!  Subscribe to Hurrdat Entertainment's ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube Channel⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for full length video episodes!  Follow me on Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@thebravoinvestigator⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Follow me on Tik Tok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@thebravoinvestigator⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Email me your questions or suggestions: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Brunchandbravo@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  This is another Hurrdat Media Production. Hurrdat Media is a podcast network and digital media production company based in Omaha, NE. Find more podcasts on the Hurrdat Media Network by going to HurrdatMedia.com or the Hurrdat Media YouTube channel!  Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's episode, we'll learn more about social determinants of health that impact access to allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia, or AML; use of megakaryocyte growth factor receptor-based stem cell depletion as part of pretransplant conditioning in ex vivo autologous gene therapy; and identification of an eight-protein risk signature as well as a novel single protein biomarker, soluble oncostatin M receptor, for risk stratification in AML.Featured Articles:Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiacMPL-Based Purification and Depletion of Human Hematopoietic Stem Cells: Implications for Pretransplant ConditioningBlood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML Outcomes

In today's episode, we had the pleasure of speaking with Alexey Danilov, MD, PhD, about current challenges and emerging treatment approaches for the management of leukemia and lymphoma that were published in a manuscript based on proceedings from the inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference. Dr Danilov is the Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, co-director of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California. In our exclusive interview, Dr Danilov highlighted recent advances and controversies in the treatment of select patients with hematologic malignancies. He noted chemotherapy-free regimens that are shifting treatment paradigms in mantle cell lymphoma, preferred and emerging BTK inhibitors for the management of chronic lymphocytic leukemia, and the evolution of CD19-directed CAR T-cell therapies for diffuse large B-cell lymphoma. Dr Danilov concluded by taking a forward glance at future developments like BTK degraders and novel CAR T-cell therapy targets.

Blood editor Dr. Laurie Sehn discusses the topic of "Aggressive non-Hodgkin lymphoma: defining and managing high-risk subsets" featuring Drs. Mark Roschewski, Grzegorz Nowakowski, and Neha Mehta-Shah, who each contributed to the articles featured in the review series on high-risk aggressive lymphoma.See the full review series on high risk lymphoma in volume 144, issue 25 of Blood.

This episode of Marrow Masters brings us an incredible conversation with Kitrena Young, a two-time cancer survivor whose story spans decades and highlights the unique challenges faced by adolescents and young adults (AYAs). We begin by learning about Kitrena's initial diagnosis of B-cell ALL with a Philadelphia chromosome at the age of eight, followed by a shocking relapse 23 years later. Her candor about how she recognized the early signs the second time around—bruising and fatigue—underscores the importance of self-awareness and advocacy.We discuss how navigating the adult healthcare system differed drastically from her pediatric experience. Kitrena takes us through her rapid efforts to get an urgent appointment and the emotional toll of being thrust back into the cancer world. With support from her brother and eventually finding care at the Memorial Sloan Kettering Cancer Center (MSKCC)  through a compassionate voice on the phone, she exemplifies what it means to be proactive in your care journey.Fertility preservation is another focal point. Kitrena recounts her decision to freeze 15 eggs before starting treatment and how her perspective on parenthood has evolved. She walks us through the emotional and physical realities of exploring surrogacy and genetic testing post-transplant—particularly the complex issue of donor DNA requiring a skin biopsy for viable results.Kitrena doesn't shy away from discussing post-treatment life: weight gain linked to early menopause, a challenging international trip filled with setbacks and triumphs, and the frustrations of altered tastes and capabilities. Despite it all, she maintains a remarkable sense of humor and determination to continue traveling and living fully.Family and caregiver dynamics are woven throughout her story. She speaks lovingly about her partner's unwavering support and the strength of her younger brother, who stepped up when needed most. Her message to caregivers includes practical advice—especially around vigilance with medical billing, noting errors she encountered from appointments she never attended.Finally, Kitrena emphasizes the growing importance of therapy for both patients and caregivers. She encourages the AYA community to use available resources to work through trauma, grief, and uncertainty—pointing to virtual options that didn't exist in her earlier experience.Kitrena's journey is one of persistence, clarity, and empowerment. She brings vital, firsthand wisdom to the AYA cancer space, reminding us that while every survivor's path is different, no one should walk it alone.Thanks to our Season 17 Sponsors:Leukemia and Lymphoma Society (LLS): https://lls.org/and Incyte: https://incyte.com/FInancial Resource from the LINK: https://www.nbmtlink.org/financebookresources/ National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.To participate in the GVHD Mosaic, click here: https://amp.livemosaics.com/gvhd

In today's episode, supported by Shorla Oncology, we had the pleasure of speaking with Kate Gasparini, PharmD, BCOP, BCPPS, about the use of the oral formulation of imatinib (Imkeldi) for pediatric and adult patients with select leukemias and other malignancies. Gasparini is a pediatric oncology clinical pharmacy specialist at Memorial Sloan Kettering Cancer Center in New York, New York. In our exclusive interview, Gasparini discussed her role as a clinical pharmacy specialist in pediatric oncology, emphasizing her work in patient care, medication reviews, and supportive care. She also noted challenges in administering treatments to patients with dysphagia and emphasized the need for liquid formulations of common therapies. She explained the significance of the availability of the liquid formulation of imatinib, sharing its benefits for patients who struggle with swallowing. Gasparini also addressed potential barriers to accessing this medication, such as insurance coverage limitations, as well as the importance of considering the volume and palatability of liquid formulations to avoid adverse effects and ensure treatment adherence.

Celebrating Fathers and the Impact of FatherhoodIn this special Father's Day episode of the Truman Charities podcast, host Jamie Truman celebrates fathers, particularly her husband Jerry Truman, co-founder of Truman Charities. Jamie outlines how Truman Charities started with Jerry's initiative to raise funds for Leukemia research and has since grown, raising over $2 million. She discusses the significant impact fathers have within the family unit and the alarming statistics on youths without fathers. Jamie shares insights from her book 'Vanishing Fathers: The Ripple Effect on Tomorrow's Generation,' which explores the societal consequences of fatherlessness. Proceeds from the book support at-risk youth charities. The episode features discussions with notable individuals impacted by fatherlessness,00:00 Introduction and Father's Day Wishes00:26 The Origin of Truman Charities01:23 The Importance of Fathers04:10 Vanishing Fathers: The Book04:28 Notable Interviews and Stories06:34 Supporting At-Risk Youths06:54 Final Thoughts and Upcoming EventsConnect with Jamie at Truman Charities:FacebookInstagramLinkedInWebsiteYouTubeEmail: info@trumancharities.comThis episode was post produced by Podcast Boutique https://podcastboutique.com/

In today's episode, we spoke with Naval Daver, MD, about the evolving role of menin inhibition in acute myeloid leukemia (AML) and emerging data with revumenib (Revuforj) presented across ongoing clinical trials. Dr Daver is a professor in the Department of Leukemia and director of the Leukemia Research Alliance Program at The University of Texas MD Anderson Cancer Center in Houston, Texas.

In this week's episode, we' ll learn about how TET3 has a key role in GVHD. In mice, a deficiency of Tet3 in donor T cells inhibited pathogenic immunoglobulin class switching and suppressed lung fibrosis. Accordingly, TET3 may be a new therapeutic target in chronic GVHD. After that: rilzabrutinib, a BTK inhibitor for ITP. In a randomized, placebo-controlled trial, treatment produced rapid and durable platelet responses, with acceptable safety, in adults with immune thrombocytopenia who had failed multiple previous therapies. Finally: exploring pre-TCR surface expression patterns in T-cell ALL. Co-inhibition of the interleukin-7 receptor and pre-T cell receptor pathways may play a therapeutic role for a subset of T-lymphoblastic leukemias.Featured Articles: Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHDSafety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 studySurface pTα expression predicts LCK activation and preclinical synergy of LCK and JAK coinhibition in adult T-ALL

Valerie David, also known as The Pink Hulk, is a three-time cancer survivor (non-Hodgkin's lymphoma, stage 2 breast cancer, and stage 4 metastatic breast cancer) who turned her journey of resilience into an award-winning one-woman show. Through humor, raw honesty, and advocacy, she inspires audiences worldwide—proving that even cancer won't stop her from taking center stage.Check out Valerie's show, The Pink Hulk here: https://pinkhulkplay.comKey Highlights:- Valerie trusted her inner voice when symptoms appeared, even when doctors initially dismissed them. If you are able to get second opinions, advocate for yourself, and listen to your gut, you'll find this to be useful in other parts of your own life.- Balancing intuition with fear over symptoms can be tricky, but Valerie advises: don't panic over nothing, don't choose to live in fear. Instead, stay proactive by communicating with your care team about any arising symptoms.About our guest:Valerie David is an actor, playwright, writer and editor. Her greatest accomplishment in life is being a three-time cancer survivor. She was diagnosed and treated for Stage III Non-Hodgkin's Lymphoma in 1999, Stage II Breast Cancer in 2014 and 2015, and Stage IV Breast Cancer in 2018. As of April 2019, she has beaten cancer again! Valerie reactivated her superhero within, and exactly 5 months after receiving hormone treatment only in pill form–no surgery, no radiation, no chemotherapy, Valerie no longer has active disease. She has since kept up a full schedule of performances–nothing has stopped her. Valerie's inspirational solo show, The Pink Hulk, has been accepted into almost 50 different play festivals worldwide since its 2016 debut, won multiple awards and has been touring since its very first performance, impacting audiences with the show's universal message of hope and empowerment. She has performed in over 25 different cities and globally, including in England, Sweden, Iceland, and Finland. A graduate of the American Academy of Dramatic Arts, her credits include the Off-Broadway production of A Stoop on Orchard Street, Cookie in Rumors and Claudia Shear's Blown Sideways Through Life. Films: How I Became that Jewish Guy, which premiered at a November 2015 NYC Film Festival, and Bridges and Tunnels. Valerie volunteers as a motivational speaker at the Leukemia & Lymphoma Society's Team in Training events and Make-A-Wish Foundation. As a marathon cyclist, she co-founded Cycle of Hope, which raises money for national and international cancer organizations through bike marathons. Her most recent biking event raised almost $5,000 for the American Cancer Society and the Leukemia & Lymphoma Society.Key Moments:At 7 minutes 28 seconds “What is my choice? Is my choice going to live in fear every single day? Is it going to be well, we'll deal with it when it happens. So I think what I've learned from cancer is don't worry until there's something to worry about.”Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

In this special episode, Dr. Shaji Kumar from the Mayo Clinic speaks with Blood editor Dr. Laurie Sehn on a paper recently published in Blood, "Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma". The findings demonstrate eliminating the need for sequential confirmation of response in multiple myeloma. The study, involving 583 episodes of progression, found that simultaneous confirmation of disease progression using two different markers (e.g., serum protein electrophoresis and serum free light chain assay) was 98% accurate, compared to 82% for sequential confirmation. This suggests that simultaneous confirmation could improve clinical trial accuracy and reduce false censoring. The International Myeloma Working Group is set to revise its response criteria to incorporate these findings, potentially simplifying disease assessment and reducing the need for multiple blood draws.

To have your question featured in a future video, please email: questions@morses.tv Please include at least: Age, Weight and as much history as possible.

Livvy Bedard and Caeleigh Brown met while on the Swimming Team in Middle School. Caeleigh was diagnosed with Leukemia while a member of this team in January of 2017, shortly after setting her personal best during a swimming meet. Caleigh is now a Nursing Student at James Madison University. Livvy is working with the Leukemia and Lymphoma Society as she attempts to become a Visionary of the Year by raising money in honor of Caeleigh and what she went through. Livvy began this quest on March 27th and has an upcoming fundraising deadline of June 5th. 

Angela started her career as a critical care nurse in 2014. She received her first MSN in 2017 with an emphasis in public health. In 2022, she received her 2nd MSN in Adult/Gerontology Acute Care Nurse Practitioner. She and her husband have been practicing the Keto Diet since 2019 (which was right before COVID and one of their children being diagnosed with Leukemia); with all the stressors that they faced, the Keto Diet kept them healthy and happy through the worst. Disenchanted by modern medicine after learning about the keto diet and reluctant to make the transition as an NP, Angela found her way into Home Health as a Telehealth Primary and Palliative Care NP. Timestamps: 00:00 Trailer 01:25 Introduction 03:15 Nurse practitioner's independence benefits 09:14 ICU nutrition oversights during Covid 11:58 Keto diet and health struggles 14:19 Diet scams vs. genuine support 19:10 Orthopedic surgeon embraces metabolic health 22:33 Low carb lifestyle and nutrition 27:41 Rapid monitoring of hypertension patients 29:42 Revero's unique healthcare model 32:28 Balancing work and family time 34:58 Nutrition and nursing home residents 38:48 Improving elder care nutrition 42:18 Patients' surprising knowledge on keto/carnivore 45:10 Patient struggles in gaining weight 51:13 Creating a positive impact for patients 52:05 Where to find Skye Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.